PubMed

Development of a novel small antibody that retains specificity for tumor targeting.

Zhen ZP, Zhang J, Zhang SY.

J Exp Clin Cancer Res. 2009 Apr 30;28:59.PMID: 19405947 [PubMed - indexed for MEDLINE]Related articlesFree article

Enhanced inhibition of murine tumor and human breast tumor xenografts using targeted delivery of an antibody-endostatin fusion protein.

Cho HM, Rosenblatt JD, Kang YS, Iruela-Arispe ML, Morrison SL, Penichet ML, Kwon YG, Kim TW, Webster KA, Nechustan H, Shin SU.

Mol Cancer Ther. 2005 Jun;4(6):956-67.PMID: 15956253 [PubMed - indexed for MEDLINE]Related articlesFree article

Single-chain antibody/activated BID chimeric protein effectively suppresses HER2-positive tumor growth.

Qiu XC, Xu YM, Wang F, Fan QY, Wang LF, Ma BA, Jia LT, Zhao J, Meng YL, Yao LB, Chen SY, Yang AG.

Mol Cancer Ther. 2008 Jul;7(7):1890-9.PMID: 18644999 [PubMed - indexed for MEDLINE]Related articlesFree article

Pronounced antitumor efficacy by extracellular activation of a doxorubicin-glucuronide prodrug after adenoviral vector-mediated expression of a human antibody-enzyme fusion protein.

de Graaf M, Pinedo HM, Oosterhoff D, van der Meulen-Muileman IH, Gerritsen WR, Haisma HJ, Boven E.

Hum Gene Ther. 2004 Mar;15(3):229-38.PMID: 15018732 [PubMed - indexed for MEDLINE]Related articles

Antibody-dependent cell-mediated cytotoxicity effector-enhanced EphA2 agonist monoclonal antibody demonstrates potent activity against human tumors.

Bruckheimer EM, Fazenbaker CA, Gallagher S, Mulgrew K, Fuhrmann S, Coffman KT, Walsh W, Ready S, Cook K, Damschroder M, Kinch M, Kiener PA, Woods R, Gao C, Dall'Acqua W, Wu H, Coats S.

Neoplasia. 2009 Jun;11(6):509-17, 2 p following 517.PMID: 19484140 [PubMed - indexed for MEDLINE]Related articlesFree article

Construction and characterization of novel, recombinant immunotoxins targeting the Her2/neu oncogene product: in vitro and in vivo studies.

Cao Y, Marks JD, Marks JW, Cheung LH, Kim S, Rosenblum MG.

Cancer Res. 2009 Dec 1;69(23):8987-95. Epub 2009 Nov 24.PMID: 19934334 [PubMed - indexed for MEDLINE]Related articles

A novel vaccine targeting gastrin-releasing peptide: efficient inhibition of breast cancer growth in vivo.

Guojun W, Wei G, Kedong O, Yi H, Yanfei X, Qingmei C, Yankai Z, Jie W, Hao F, Taiming L, Jingjing L, Rongyue C.

Endocr Relat Cancer. 2008 Mar;15(1):149-59.PMID: 18310283 [PubMed - indexed for MEDLINE]Related articlesFree article

Inhibition of adhesion, invasion, and metastasis by antibodies targeting CEACAM6 (NCA-90) and CEACAM5 (Carcinoembryonic Antigen).

Blumenthal RD, Hansen HJ, Goldenberg DM.

Cancer Res. 2005 Oct 1;65(19):8809-17.PMID: 16204051 [PubMed - indexed for MEDLINE]Related articlesFree article

Targeting IL-13Ralpha2-positive cancer with a novel recombinant immunotoxin composed of a single-chain antibody and mutated Pseudomonas exotoxin.

Kioi M, Seetharam S, Puri RK.

Mol Cancer Ther. 2008 Jun;7(6):1579-87.PMID: 18566228 [PubMed - indexed for MEDLINE]Related articlesFree article

Efficient killing of CD22+ tumor cells by a humanized diabody-RNase fusion protein.

Krauss J, Arndt MA, Vu BK, Newton DL, Seeber S, Rybak SM.

Biochem Biophys Res Commun. 2005 Jun 3;331(2):595-602.PMID: 15850802 [PubMed - indexed for MEDLINE]Related articles

Conversion of murine antibodies to human antibodies and their optimization for ovarian cancer therapy targeted to the folate receptor.

Figini M, Martin F, Ferri R, Luison E, Ripamonti E, Zacchetti A, Mortarino M, Di Cioccio V, Maurizi G, Allegretti M, Canevari S.

Cancer Immunol Immunother. 2009 Apr;58(4):531-46. Epub 2008 Aug 15.PMID: 18704410 [PubMed - indexed for MEDLINE]Related articles

Binding activities and antitumor properties of a new mouse/human chimeric antibody specific for GD2 ganglioside antigen.

Alvarez-Rueda N, Leprieur S, Clémenceau B, Supiot S, Sébille-Rivain V, Faivre-Chauvet A, Davodeau F, Paris F, Barbet J, Aubry J, Birklé S.

Clin Cancer Res. 2007 Sep 15;13(18 Pt 2):5613s-5620s.PMID: 17875797 [PubMed - indexed for MEDLINE]Related articlesFree article

TMTP1, a novel tumor-homing peptide specifically targeting metastasis.

Yang W, Luo D, Wang S, Wang R, Chen R, Liu Y, Zhu T, Ma X, Liu R, Xu G, Meng L, Lu Y, Zhou J, Ma D.

Clin Cancer Res. 2008 Sep 1;14(17):5494-502.PMID: 18765541 [PubMed - indexed for MEDLINE]Related articlesFree article

Immunomodulatory oligonucleotides as novel therapy for breast cancer: pharmacokinetics, in vitro and in vivo anticancer activity, and potentiation of antibody therapy.

Wang H, Rayburn ER, Wang W, Kandimalla ER, Agrawal S, Zhang R.

Mol Cancer Ther. 2006 Aug;5(8):2106-14.PMID: 16928832 [PubMed - indexed for MEDLINE]Related articlesFree article

Targeting a methioninase-containing fusion protein to breast cancer urokinase receptors inhibits growth and migration.

Zang XP, Palwai NR, Lerner MR, Brackett DJ, Pento JT, Harrison RG.

Anticancer Res. 2006 May-Jun;26(3A):1745-51.PMID: 16827102 [PubMed - indexed for MEDLINE]Related articles

Enhancement of antibody-dependent mechanisms of tumor cell lysis by a targeted activator of complement.

Imai M, Ohta R, Varela JC, Song H, Tomlinson S.

Cancer Res. 2007 Oct 1;67(19):9535-41.PMID: 17909064 [PubMed - indexed for MEDLINE]Related articlesFree article

Tumor radioimmunolocalization in nude mice by mono- and divalent- single-chain Fv antiplacental alkaline phosphatase antibodies.

Sheikholvaezin A, Eriksson D, Ahlström KR, Johansson L, Stigbrand T.

Cancer Biother Radiopharm. 2007 Feb;22(1):64-72.PMID: 17627415 [PubMed - indexed for MEDLINE]Related articles

Direct in vivo intracellular selection of conformation-sensitive antibody domains targeting Alzheimer's amyloid-beta oligomers.

Meli G, Visintin M, Cannistraci I, Cattaneo A.

J Mol Biol. 2009 Apr 3;387(3):584-606. Epub 2009 Feb 4.PMID: 19361429 [PubMed - indexed for MEDLINE]Related articles

Antiangiogenesis targeting tumor microenvironment synergizes glucuronide prodrug antitumor activity.

Juan TY, Roffler SR, Hou HS, Huang SM, Chen KC, Leu YL, Prijovich ZM, Yu CP, Wu CC, Sun GH, Cha TL.

Clin Cancer Res. 2009 Jul 15;15(14):4600-11. Epub 2009 Jul 7.PMID: 19584154 [PubMed - indexed for MEDLINE]Related articles

A novel reduced immunogenicity bispecific targeted toxin simultaneously recognizing human epidermal growth factor and interleukin-4 receptors in a mouse model of metastatic breast carcinoma.

Oh S, Stish BJ, Sachdev D, Chen H, Dudek AZ, Vallera DA.

Clin Cancer Res. 2009 Oct 1;15(19):6137-47. Epub 2009 Sep 29.PMID: 19789305 [PubMed - indexed for MEDLINE]Related articles